A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival.
See a new article here
- Just Diagnosed?
- About Ovarian Cancer
- Resources
- Advocacy
- Get Involved
A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival.
See a new article here
All content © Copyright 2013 by Ovarian Cancer National Alliance.
Subscribe to our RSS Feed or view our Sitemap
Privacy Policy
This site made possible by a grant from Novartis Oncology
